Join us for an insightful webinar featuring experts, including CosmosID’s Manoj Dadlani, where we discuss the latest advancements in understanding the novel coronavirus, SARS-CoV-2. This session, supported by the National Institute of Standards and Technology (NIST), will explore cutting-edge research, diagnostics, and the critical role of genomics in combating the pandemic. Don’t miss this opportunity to gain a deeper understanding of SARS-CoV-2 from leading professionals in the field. Watch the webinar below.
The current pandemic is due to the spread of SARS-CoV-2, a novel coronavirus that causes a severe respiratory infection known as COVID-19. Recent reports have noted the presence of viral RNA in stool samples, offering unique measurement challenges and opportunities in three areas:
Biosurveillance of Wastewater: Local public health labs can monitor sewage treatment facilities to measure the rise and fall of COVID-19 in a community; potentially as a tool to help predict future waves of outbreaks.
Feces as a New Target for Diagnostic Testing: Currently there are >140 commercially available COVID-19 diagnostic tests. While initially validated using nasal swabs, these same tests can potentially be re-validated in fecal material.
Fecal Microbiome Transplantation (FMT) Safety: Every year, thousands of patients receive FMTs to treat infections and other health conditions. The FDA has released a safety alert stating donor material must be screened for COVID-19, as feasible.
1:00 pm Scott Jackson, NIST, Opening Remarks
1:05 pm Bharat Ramakrishna, OpenBiome, “Fecal microbiota transplantation: Responding to the COVID-19 pandemic”
1:20 pm Manoj Dadlani, CosmosID, “Overcoming the Validation Challenges of a Diagnostic for SARS-CoV-2 in Stool”
1:35 pm Katerina Papp, Water Quality R&D, Southern Nevada Water Authority, “Wastewater Surveillance of SARS-CoV-2 in Southern Nevada: Challenges for Sample Collection, Processing, and Analysis”
1:50 pm Kyle Bibby, University of Notre Dame, Title TBA
2:05 pm Aparna Keshaviah, Mathematica, “Testing Wastewater for SARS-CoV-2: Aligning Validation and Policy Needs”
2:20 pm Panelist Q&A
2:55 pm Scott Jackson, NIST, Wrap-Up
3:00 pm Conclude Webinar
If you want to know more about the uses and development of methodologies for microbiome studies produced and supported by the CosmosID team, check out the webinars we organised some time ago for experts and other interested parties.
#10 – Utilising Metagenomics in Early to Late-Stage R&D
#9 – Autism and the Microbiome
#8 – Microbiota Transplant for Autism
#7 – Development of a Universal Detection Methodology for Foodborne Microbial Pathogens
#6 – Host-microbes Symbioses in Autistic Spectrum Disorders
#5 – Unlocking the Gut-Skin Axis
#4 – Unlocking the Oral Microbiome
#3 – Standards for Microbiome and Metagenomics
#2 – Measuring SARS-CoV-2 in Wastewater and Fecal Material (Current page)
© 2023 CosmosID. All rights reserved